Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: Microwave Ablation|DRUG: Camrelizumab|PROCEDURE: Breast Surgery
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Collaborators: Jiangsu HengRui Medicine Co., Ltd.